1. Home
  2. TVTX vs CRI Comparison

TVTX vs CRI Comparison

Compare TVTX & CRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • CRI
  • Stock Information
  • Founded
  • TVTX 2008
  • CRI 1865
  • Country
  • TVTX United States
  • CRI United States
  • Employees
  • TVTX N/A
  • CRI N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • CRI Apparel
  • Sector
  • TVTX Health Care
  • CRI Consumer Discretionary
  • Exchange
  • TVTX Nasdaq
  • CRI Nasdaq
  • Market Cap
  • TVTX 1.4B
  • CRI 1.2B
  • IPO Year
  • TVTX N/A
  • CRI 2003
  • Fundamental
  • Price
  • TVTX $16.48
  • CRI $32.86
  • Analyst Decision
  • TVTX Strong Buy
  • CRI Sell
  • Analyst Count
  • TVTX 16
  • CRI 5
  • Target Price
  • TVTX $33.33
  • CRI $36.80
  • AVG Volume (30 Days)
  • TVTX 1.5M
  • CRI 1.5M
  • Earning Date
  • TVTX 07-31-2025
  • CRI 07-25-2025
  • Dividend Yield
  • TVTX N/A
  • CRI 9.66%
  • EPS Growth
  • TVTX N/A
  • CRI N/A
  • EPS
  • TVTX N/A
  • CRI 4.51
  • Revenue
  • TVTX $273,533,000.00
  • CRI $2,812,437,000.00
  • Revenue This Year
  • TVTX $73.84
  • CRI N/A
  • Revenue Next Year
  • TVTX $46.72
  • CRI N/A
  • P/E Ratio
  • TVTX N/A
  • CRI $7.33
  • Revenue Growth
  • TVTX 75.65
  • CRI N/A
  • 52 Week Low
  • TVTX $7.93
  • CRI $29.36
  • 52 Week High
  • TVTX $25.29
  • CRI $71.99
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 59.73
  • CRI 55.60
  • Support Level
  • TVTX $14.44
  • CRI $30.68
  • Resistance Level
  • TVTX $16.64
  • CRI $33.99
  • Average True Range (ATR)
  • TVTX 0.61
  • CRI 1.31
  • MACD
  • TVTX 0.31
  • CRI 0.38
  • Stochastic Oscillator
  • TVTX 94.18
  • CRI 75.49

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

Share on Social Networks: